Top 10 Companies in the Global Pharmaceutical Methanesulfonic Acid Market (2026): Market Leaders Powering Global Pharmaceutical Production

The Global Pharmaceutical Methanesulfonic Acid market was valued at USD 180 million in 2024 and is projected to reach USD 240 million by 2030, at a CAGR of 4.9% during the forecast period.

Report Overview
Methanesulfonic Acid is a strong organic acid which is highly suitable for manufacturing active pharmaceutical ingredients such as Telmisartan and Eprosartan, Angiotensin II receptor antagonists.
This report provides a deep insight into the Global Pharmaceutical Methanesulfonic Acid market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Methanesulfonic Acid Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Methanesulfonic Acid market in any manner.
Global Pharmaceutical Methanesulfonic Acid Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Global Pharmaceutical Methanesulfonic Acid Market – View in Detailed Research Report

---

🔟 1. BASF

Headquarters: Ludwigshafen, Germany
Key Offering: Pharmaceutical grade Methanesulfonic Acid (Powder & Liquid)

BASF is a global leader in chemical manufacturing, offering high‑purity Methanesulfonic Acid used in the synthesis of antihypertensive drugs. The company’s extensive R&D network ensures continuous improvement in product quality and supply reliability.

Sustainability & Growth Initiatives:

• Investing in greener solvent alternatives to reduce environmental impact.
• Expanding capacity in Asia‑Pacific to meet rising demand for pharmaceutical intermediates.
• Collaborating with pharmaceutical firms to develop safer synthesis routes.

9️⃣ 2. Arkema

Headquarters: Paris, France
Key Offering: High‑purity Methanesulfonic Acid for active pharmaceutical ingredient production

Arkema’s specialty chemicals division supplies Methanesulfonic Acid to leading pharma companies, emphasizing quality and regulatory compliance. The firm leverages its global distribution network to serve markets across North America and Europe.

Sustainability & Growth Initiatives:

• Adopting circular economy practices in chemical production.
• Developing bio‑based solvent alternatives to lower carbon footprint.
• Strategic partnerships with contract manufacturers to expand market reach.

8️⃣ 3. Oxon Italia

Headquarters: Milan, Italy
Key Offering: Liquid Methanesulfonic Acid for pharmaceutical synthesis

Oxon Italia focuses on providing high‑grade solvents for medicinal chemistry. The company’s product portfolio includes both powder and liquid forms, catering to diverse manufacturing processes.

Sustainability & Growth Initiatives:

• Investing in energy‑efficient production lines.
• Expanding research into low‑toxicity solvent systems.
• Collaborating with European pharma clusters to enhance supply chain resilience.

7️⃣ 4. Jinshenghui Chemical

Headquarters: Shanghai, China
Key Offering: Powdered Methanesulfonic Acid for large‑scale pharmaceutical production

Jinshenghui Chemical serves the rapidly growing Chinese pharma market, providing cost‑effective and high‑purity Methanesulfonic Acid for drug intermediates.

Sustainability & Growth Initiatives:

• Implementing waste‑water recycling systems in production plants.
• Scaling up production capacity to meet domestic demand.
• Engaging in joint ventures with global pharma suppliers.

6️⃣ 5. Zhongke Fine Chemical

Headquarters: Beijing, China
Key Offering: Liquid Methanesulfonic Acid for medicinal chemistry

Zhongke Fine Chemical specializes in high‑purity solvents for pharmaceutical synthesis, with a strong presence in the Asian market.

Sustainability & Growth Initiatives:

• Adopting green chemistry principles in production.
• Investing in advanced purification technologies.
• Expanding distribution networks across Southeast Asia.

5️⃣ 6. Xingchi Science and Technology

Headquarters: Wuhan, China
Key Offering: Powder Methanesulfonic Acid for pharmaceutical intermediates

Xingchi Science and Technology provides high‑grade Methanesulfonic Acid to contract manufacturers and research institutions, focusing on cost efficiency.

Sustainability & Growth Initiatives:

• Implementing energy‑saving production processes.
• Developing eco‑friendly solvent alternatives.
• Strengthening collaborations with universities for R&D.

4️⃣ 7. Suning Chemical

Headquarters: Shenzhen, China
Key Offering: Liquid Methanesulfonic Acid for pharmaceutical synthesis

Suning Chemical offers a broad range of solvents, including Methanesulfonic Acid, supporting the growth of the Chinese pharmaceutical sector.

Sustainability & Growth Initiatives:

• Investing in renewable energy for manufacturing plants.
• Expanding product line to include biodegradable solvents.
• Enhancing supply chain transparency through digital platforms.

3️⃣ 8. Jinji Chemical

Headquarters: Guangzhou, China
Key Offering: Powdered Methanesulfonic Acid for drug intermediates

Jinji Chemical supplies high‑purity Methanesulfonic Acid to pharmaceutical manufacturers across Asia, focusing on reliability and compliance.

Sustainability & Growth Initiatives:

• Implementing waste‑minimization strategies.
• Developing low‑toxicity solvent systems.
• Expanding export capabilities to Europe and the Americas.

2️⃣ 9. Yanuo Chemical

Headquarters: Tianjin, China
Key Offering: Liquid Methanesulfonic Acid for medicinal chemistry

Yanuo Chemical provides high‑grade solvents for pharmaceutical R&D, with a focus on quality and regulatory compliance.

Sustainability & Growth Initiatives:

• Adopting green production technologies.
• Investing in process automation to reduce waste.
• Strengthening partnerships with global pharma firms.

1️⃣ 10. SHINYA CHEM

Headquarters: Shanghai, China
Key Offering: Powder and Liquid Methanesulfonic Acid for pharmaceutical intermediates

SHINYA CHEM supplies high‑purity Methanesulfonic Acid to a wide range of pharmaceutical manufacturers, emphasizing cost competitiveness.

Sustainability & Growth Initiatives:

• Implementing energy‑efficient production lines.
• Developing sustainable solvent alternatives.
• Expanding distribution to emerging markets.

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/277791/global-pharmaceutical-methanesulfonic-acid-market-2024-837

Get Full Report Here: https://www.24chemicalresearch.com/reports/277791/global-pharmaceutical-methanesulfonic-acid-market-2024-837

---

🌍 Outlook: The Future of Pharmaceutical Methanesulfonic Acid Market Is Expanding

The Pharmaceutical Methanesulfonic Acid market is experiencing dynamic growth, driven by increasing demand for high‑purity solvents in drug synthesis and the expansion of the global pharmaceutical manufacturing footprint.

📈 Key Trends Shaping the Market:

• Rising adoption of Methanesulfonic Acid in the synthesis of angiotensin II receptor antagonists and other cardiovascular drugs.
• Expansion of production capacity in Asia‑Pacific, especially China and India, to meet growing domestic and export demand.
• Strategic collaborations between chemical producers and contract manufacturers to streamline supply chains.
• Increasing focus on green chemistry, leading to the development of low‑toxicity solvent alternatives.

The companies listed above are not only key suppliers of Methanesulfonic Acid but also pioneers in driving the green and efficient synthesis of pharmaceutical intermediates.